SPONSOR
Anhui Provincial Hospital
Total Trials
7
Recruiting
7
Phases
Phase 2, EARLY_Phase 1
Conditions studied: Intrahepatic CholangiocarcinomaImmune Thrombocytopenia (ITP)Chemotherapy-induced NeutropeniaPlatelet Recovery After Umbilical Cord Blood TransplantationMultiple Myeloma (MM)Plasma Cell Leukemia (PCL)AL Amyloidosis (AL)High Titers of Anti-HLA Antibody (MFI ≥5000)Hepatocellular Carcinoma (HCC)
Anhui Provincial Hospital is a clinical research sponsor with 7 registered studies on ClinicalTrials.gov, of which 7 are actively recruiting participants. Research covers conditions including Intrahepatic Cholangiocarcinoma, Immune Thrombocytopenia (ITP), Chemotherapy-induced Neutropenia, Platelet Recovery After Umbilical Cord Blood Transplantation.
The trial portfolio spans Phase 2, EARLY_Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Anhui Provincial Hospital
How many clinical trials has Anhui Provincial Hospital sponsored?
ClinicalMetric currently tracks 7 clinical trials sponsored by Anhui Provincial Hospital, of which 7 are actively recruiting participants. These trials cover conditions including Intrahepatic Cholangiocarcinoma, Immune Thrombocytopenia (ITP), Chemotherapy-induced Neutropenia. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Anhui Provincial Hospital research focus on?
Anhui Provincial Hospital clinical trials span Intrahepatic Cholangiocarcinoma, Immune Thrombocytopenia (ITP), Chemotherapy-induced Neutropenia, Platelet Recovery After Umbilical Cord Blood Transplantation, Multiple Myeloma (MM), and additional conditions. The research pipeline includes Phase 2, EARLY_Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Anhui Provincial Hospital clinical trial?
To participate in a Anhui Provincial Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Anhui Provincial Hospital trials with current recruitment status updated daily.
Clinical Trials by Anhui Provincial Hospital
NCT06664021 Phase 2
Recruiting
Exploring the Efficacy and Safety of Tislelizumab in Combination With S-1 in the Treatment of Patients With Postoperative Recurrent High-risk Intrahepatic Cholangiocarcinoma
Intrahepatic Cholangiocarcinoma
NCT06973356
Recruiting
Anti CD19/BCMA CAR Gene Therapy for Relapsed/Refractory Immune Thrombocytopenia
Immune Thrombocytopenia (ITP)
NCT07096479
Recruiting
Telpegfilgrastim Injection to Reduce the Risk of Neutropenia in Patients With Solid Tumor
Chemotherapy-induced Neutropenia
NCT06693791 Phase 2
Recruiting
Romiplostim N01 for Platelet Recovery in Adult Hematologic Malignancies Patients Undergoing UCBT
Platelet Recovery After Umbilical Cord Blood Transplantation
NCT07085559 EARLY_Phase 1
Recruiting
Safety and Efficacy of Metabolically Armed BCMA CAR-T Cells (Meta10-BCMA) in the Treatment of r/r Plasma Cell Neoplasms Clinical Research
Multiple Myeloma (MM)
NCT06362967 Phase 2
Recruiting
The Efficacy and Safety of Desensitation Regimen for Patients With High Titers of Anti-HLA Antibodies Prior to Allo-HSCT
High Titers of Anti-HLA Antibody (MFI ≥5000)
NCT07782632
Recruiting
Liver Volume Metrics for Predicting Immunotherapy Prognosis in Unresectable Hepatocellular Carcinoma
Hepatocellular Carcinoma (HCC)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology